831 related articles for article (PubMed ID: 8666133)
1. Wortmannin inhibits insulin secretion in pancreatic islets and beta-TC3 cells independent of its inhibition of phosphatidylinositol 3-kinase.
Gao Z; Konrad RJ; Collins H; Matschinsky FM; Rothenberg PL; Wolf BA
Diabetes; 1996 Jul; 45(7):854-62. PubMed ID: 8666133
[TBL] [Abstract][Full Text] [Related]
2. A link between insulin resistance and hyperinsulinemia: inhibitors of phosphatidylinositol 3-kinase augment glucose-induced insulin secretion from islets of lean, but not obese, rats.
Zawalich WS; Zawalich KC
Endocrinology; 2000 Sep; 141(9):3287-95. PubMed ID: 10965900
[TBL] [Abstract][Full Text] [Related]
3. Phosphatidylinositol 3-kinase mediates the inhibitory effect of epidermal growth factor on calcium-dependent chloride secretion.
Uribe JM; Keely SJ; Traynor-Kaplan AE; Barrett KE
J Biol Chem; 1996 Oct; 271(43):26588-95. PubMed ID: 8900131
[TBL] [Abstract][Full Text] [Related]
4. A wortmannin-sensitive signal transduction pathway is involved in the stimulation of insulin release by vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide.
Straub SG; Sharp GW
J Biol Chem; 1996 Jan; 271(3):1660-8. PubMed ID: 8576167
[TBL] [Abstract][Full Text] [Related]
5. Phosphatidylinositol 3-kinase suppresses glucose-stimulated insulin secretion by affecting post-cytosolic [Ca(2+)] elevation signals.
Eto K; Yamashita T; Tsubamoto Y; Terauchi Y; Hirose K; Kubota N; Yamashita S; Taka J; Satoh S; Sekihara H; Tobe K; Iino M; Noda M; Kimura S; Kadowaki T
Diabetes; 2002 Jan; 51(1):87-97. PubMed ID: 11756327
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of phosphatidylinositol 3-kinase amplify insulin release from islets of lean but not obese mice.
Zawalich WS; Tesz GJ; Zawalich KC
J Endocrinol; 2002 Aug; 174(2):247-58. PubMed ID: 12176663
[TBL] [Abstract][Full Text] [Related]
7. Insulin activates ATP-sensitive K(+) channels in pancreatic beta-cells through a phosphatidylinositol 3-kinase-dependent pathway.
Khan FA; Goforth PB; Zhang M; Satin LS
Diabetes; 2001 Oct; 50(10):2192-8. PubMed ID: 11574397
[TBL] [Abstract][Full Text] [Related]
8. Endothelin-1 (ET-1)-potentiated insulin secretion: involvement of protein kinase C and the ET(A) receptor subtype.
Gregersen S; Thomsen JL; Hermansen K
Metabolism; 2000 Feb; 49(2):264-9. PubMed ID: 10690956
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of arachidonate release by secretagogue-stimulated pancreatic islets suppresses both insulin secretion and the rise in beta-cell cytosolic calcium ion concentration.
Ramanadham S; Gross RW; Han X; Turk J
Biochemistry; 1993 Jan; 32(1):337-46. PubMed ID: 8418854
[TBL] [Abstract][Full Text] [Related]
10. Transient activation of calcium-dependent phospholipase A2 by insulin secretagogues in isolated pancreatic islets.
Jolly YC; Major C; Wolf BA
Biochemistry; 1993 Nov; 32(45):12209-17. PubMed ID: 8218298
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of protein-tyrosine phosphatases stimulates insulin secretion in pancreatic islets of diabetic Goto-Kakizaki rats.
Chen J; Ostenson CG
Pancreas; 2005 May; 30(4):314-7. PubMed ID: 15841039
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of amino acids and glucose on insulin secretion from isolated rat or mouse islets.
Zawalich WS; Yamazaki H; Zawalich KC; Cline G
J Endocrinol; 2004 Nov; 183(2):309-19. PubMed ID: 15531719
[TBL] [Abstract][Full Text] [Related]
13. An inhibitory role for phosphatidylinositol 3-kinase in insulin secretion from pancreatic B cell line MIN6.
Hagiwara S; Sakurai T; Tashiro F; Hashimoto Y; Matsuda Y; Nonomura Y; Miyazaki J
Biochem Biophys Res Commun; 1995 Sep; 214(1):51-9. PubMed ID: 7669052
[TBL] [Abstract][Full Text] [Related]
14. Insulin and secretagogues differentially regulate fluid-phase pinocytosis in insulin-secreting beta-cells.
Xu G; Howland J; Rothenberg PL
Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):623-9. PubMed ID: 8809056
[TBL] [Abstract][Full Text] [Related]
15. Disruption of GLUT1 glucose carrier trafficking in L6E9 and Sol8 myoblasts by the phosphatidylinositol 3-kinase inhibitor wortmannin.
Kaliman P; Viñals F; Testar X; Palacín M; Zorzano A
Biochem J; 1995 Dec; 312 ( Pt 2)(Pt 2):471-7. PubMed ID: 8526858
[TBL] [Abstract][Full Text] [Related]
16. Glucose-Dependent Insulin Secretion in Pancreatic β-Cell Islets from Male Rats Requires Ca2+ Release via ROS-Stimulated Ryanodine Receptors.
Llanos P; Contreras-Ferrat A; Barrientos G; Valencia M; Mears D; Hidalgo C
PLoS One; 2015; 10(6):e0129238. PubMed ID: 26046640
[TBL] [Abstract][Full Text] [Related]
17. The effects of wortmannin, a potent inhibitor of phosphatidylinositol 3-kinase, on insulin-stimulated glucose transport, GLUT4 translocation, antilipolysis, and DNA synthesis.
Evans JL; Honer CM; Womelsdorf BE; Kaplan EL; Bell PA
Cell Signal; 1995 May; 7(4):365-76. PubMed ID: 8527305
[TBL] [Abstract][Full Text] [Related]
18. Studies of the Ca2+ requirements for glucose- and carbachol-induced augmentation of inositol trisphosphate and inositol tetrakisphosphate accumulation in digitonin-permeabilized islets. Evidence for a glucose recognition site in insulin secretion.
Wolf BA; Florholmen J; Turk J; McDaniel ML
J Biol Chem; 1988 Mar; 263(8):3565-75. PubMed ID: 2831191
[TBL] [Abstract][Full Text] [Related]
19. Evidence for nitric oxide mediated effects on islet hormone secretory phospholipase C signal transduction mechanisms.
Akesson B; Lundquist I
Biosci Rep; 1998 Aug; 18(4):199-213. PubMed ID: 9877233
[TBL] [Abstract][Full Text] [Related]
20. Wortmannin, a PI3-kinase inhibitor: promoting effect on insulin secretion from pancreatic beta cells through a cAMP-dependent pathway.
Nunoi K; Yasuda K; Tanaka H; Kubota A; Okamoto Y; Adachi T; Shihara N; Uno M; Xu LM; Kagimoto S; Seino Y; Yamada Y; Tsuda K
Biochem Biophys Res Commun; 2000 Apr; 270(3):798-805. PubMed ID: 10772905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
